Author Search Results

1

Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14

by Richard E. Pratley, Mansoor Husain, Ildiko Lingvay, Thomas R. Pieber, Thomas Mark, Hans A. Saevereid, Daniel Vega Møller, Bernard Zinman, the DEVOTE Study Group
Published 2019-11-01

Get full text

Article
2

Long-term Cost-effectiveness of Insulin Degludec Versus Insulin Glargine U100 in the UK: Evidence from the Basal-bolus Subgroup of the DEVOTE Trial (DEVOTE 16)

by Andersen, A., Buse, J.B, Gundgaard, J., Hallén, N., Magnuson, E.A, Marso, S.P, Pollock, R.F, the DEVOTE study group, Tutkunkardas, D., Valentine, W.J
Published 2019

Call Number: Loading...
Located: Loading...

View Fulltext in Publisher

Article

Cannot write session to /tmp/vufind_sessions/sess_idn3pi4sr89akbqrspv9e9aavu